Stockreport

Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

AKERS BIOSCIENCES INC COMMON S  (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, [Read more]